Commercial Insurance Coverage for Inflatable Penile Prosthesis at a Tertiary Care Center
This article is commented on by the following:
Abstract
Introduction:
Inflatable penile prosthesis has become an important treatment modality for men with erectile dysfunction that is refractory to medication. Despite high levels of patient satisfaction following inflatable penile prosthesis placement and inflatable penile prosthesis coverage by Medicare, coverage by commercial insurance providers is unknown. The purpose of this study was to determine the coverage of inflatable penile prosthesis by commercial insurance providers.
Methods:
Following institutional review board approval all men with erectile dysfunction interested in obtaining inflatable penile prosthesis at our tertiary care center between January 2016 and December 2017 were evaluated. We reviewed billing records for CPT code 54405 during the study period to evaluate the insurance provider for all men who received an inflatable penile prosthesis. We also reviewed a manually maintained record of excluded or denied inflatable penile prosthesis claims for men who desired inflatable penile prosthesis but could not obtain it. Through medical record review we recorded the etiology of erectile dysfunction and the specific type of insurance policy for each man.
Results:
Medicare is the most common insurer for inflatable penile prosthesis, insuring 87 of 220 (39.5%) men seeking inflatable penile prosthesis between 2016 and 2017. Among the remaining 127 men seeking inflatable penile prosthesis with commercial insurance coverage 61 (48.0%) were unable to obtain the device due to exclusions in their coverage or denials. Among commercially insured men seeking inflatable penile prosthesis 77 (62.6%) and 37 (30.0%) had health maintenance organization and preferred provider organization plans, respectively. The most prevalent indications for inflatable penile prosthesis among the entire study population were radical prostatectomy (30.9%), organic erectile dysfunction (30.5%) and diabetes mellitus (20.9%).
Conclusions:
The largest insurer for inflatable penile prosthesis in the Miami region is Medicare. While some patients seeking inflatable penile prostheses can receive insurance coverage, a large percentage (48.0%) are not able to receive coverage despite having a medical necessity for the treatment of erectile dysfunction.
References
- 1. : Penile implant for erectile impotence. J Urol 1973; 109: 641. Link, Google Scholar
- 2. : Modern utilization of penile prosthesis surgery: a national claim registry analysis. Int J Impot Res 2014; 26: 167. Google Scholar
- 3. : Assessment of psychosexual adjustment after insertion of inflatable penile prosthesis. Urology 1998; 52: 1106. Google Scholar
- 4. : Trends in the utilization of penile prostheses in the treatment of erectile dysfunction in the United States. J Sex Med 2015; 12: 1638. Google Scholar
- 5. : Penile implants: a look into the future. Transl Androl Urol, suppl., 2017; 6: S860. Google Scholar
- 6. : Evolution of penile prosthetic devices. Korean J Urol 2015; 56: 179. Google Scholar
- 7. : Assessing the variability in insurance coverage transparency for male sexual health conditions in the United States. Urology 2017; 102: 126. Google Scholar
Submitted for publication May 27, 2018.
The corresponding author certifies that, when applicable, a statement(s) has been included in the manuscript documenting institutional review board, ethics committee or ethical review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; animal approved project number.
No direct or indirect commercial, personal, academic, political, religious or ethical incentive is associated with publishing this article.
